- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01104831
The Efficacy and Cost Effectiveness of Preoperative and Postoperative Cryotherapy in Proximal Tibia Fractures (ARCTIC CAT)
May 3, 2017 updated by: University of Manitoba
Consenting patients with proximal tibia fractures will be randomized to 10 degree or 21 degree cryotherapy sleeves. Time to discharge and complications will be monitored.
Primary outcome measure: Cost of Treatment (based on length of stay) Secondary outcome measures: Satisfaction/pain relief and narcotic requirement
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Manitoba
-
Winnipeg, Manitoba, Canada, R3A 1R9
- Winnipeg Health Sciences Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
17 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Skeletally mature
- Trauma patients with single-system musculoskeletal injuries.
- Proximal tibia fractures treated with open reduction and internal fixation.
- Unilateral proximal tibial injuries.
Exclusion Criteria:
- Previous ipsilateral knee surgery
- Upper extremity injuries impairing mobilization
- Pre-existing ipsilateral neurologic condition or acute ipsilateral neurologic injury
- Associated injuries impairing mobilization
- Suspected or confirmed compartment syndrome
- Open fractures
- Patients previously on narcotics
- Patients with impaired sensorium Concurrent head injury Intoxication
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: 21 degree Cooling
Room temperature water circulated through cryotherapy sleeve.
|
sleeve with room temperature water placed over fracture site.
|
|
Active Comparator: 10 degree cooling
Cooled water circulated through a cryotherapy sleeve.
|
cooled sleeve placed over fracture site.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Cost
Time Frame: 3 months
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
VAS Pain Score
Time Frame: 2 weeks
|
2 weeks
|
|
Narcotic Requirements
Time Frame: 2 weeks
|
2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jesse A Shantz, MD, MBA, University of Manitoba
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2010
Primary Completion (Actual)
August 1, 2012
Study Completion (Actual)
November 1, 2012
Study Registration Dates
First Submitted
April 14, 2010
First Submitted That Met QC Criteria
April 14, 2010
First Posted (Estimate)
April 16, 2010
Study Record Updates
Last Update Posted (Actual)
May 8, 2017
Last Update Submitted That Met QC Criteria
May 3, 2017
Last Verified
April 1, 2011
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- B2009:035
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.